एपीए उद्धरण

Thønnings, S., Jansåker, F., Gradel, K. O., Styrishave, B., & Knudsen, J. D. (2019). Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort. Infect Drug Resist.

शिकागो स्टाइल उद्धरण

Thønnings, Sara, Filip Jansåker, Kim Oren Gradel, Bjarne Styrishave, और Jenny Dahl Knudsen. "Cefuroxime Compared to Piperacillin/tazobactam As Empirical Treatment of Escherichia Coli Bacteremia in a Low Extended-spectrum Beta-lactamase (ESBL) Prevalence Cohort." Infect Drug Resist 2019.

एमएलए उद्धरण

Thønnings, Sara, et al. "Cefuroxime Compared to Piperacillin/tazobactam As Empirical Treatment of Escherichia Coli Bacteremia in a Low Extended-spectrum Beta-lactamase (ESBL) Prevalence Cohort." Infect Drug Resist 2019.